In obesity, adipose tissue becomes a significant source of chemokines and inflammatory cytokines that are associated with chronic systemic low-grade inflammation and may lead to insulin resistance. Studies in children have mainly focused on inflammatory cytokines and there are limited data for chemokines in adolescents and young adults. We studied the relation of chemokines to cardiovascular (CV)-risk factors, insulin resistance and adipocytokines in 18-21-year-old individuals. SUBJECTS AND DESIGN: Cross-sectional data collected in a cohort originally enrolled at mean age 13, with data for the present study obtained from 252 examined at age 18.7 ± 0.1 years. METHODS: Multiple linear regression models were used to analyze the associations among chemokines (monocyte chemotactic protein-1, macrophage inflammatory protein-1b (MIP-1b), visfatin and interleukin-8 (IL-8)) and between chemokines and body mass index (BMI), glucose, lipids, blood pressure (BP), insulin resistance (euglycemic hyperinsulinemic clamp) and adipocytokines (IL-6, TNF-a and adiponectin). RESULTS: Chemokine levels were significantly intercorrelated. Significant associations (Po0.05) with adjustment for age, race and sex included: MIP-1b with waist circumference and IL-6, IL-8 with systolic BP and visfatin with IL-6. No other significant relations were found between the chemokines and the other variables. Further adjustment for BMI did not alter these conclusions. CONCLUSION: Considered in the context of prior studies in children and adults, these results suggest that in large part, the association between chemokines and CV risk or inflammatory factors does not appear to develop until adult life.
INTRODUCTION
Chemokines are a subclass of cytokines. They are secreted by inflamed or injured tissues and attract circulating leukocytes to the site of inflammation in the process of chemotaxis. 1 More recently, it has been recognized that adipose tissue is a source of chemokines, prompting the study of their relation to obesity. 2 Release of chemokines leads to infiltration of adipose tissue with leukocytes (predominantly macrophages) that secrete proinflammatory cytokines, thereby contributing to the low-grade chronic inflammation observed in obesity. 2 With increasing adiposity, chemokine production increases, sustaining chronic inflammation. 3, 4 Adipose tissue macrophage concentration has been correlated with insulin resistance, 5 suggesting that this relation may have a role in obesity-related metabolic complications. 6 As shown in mouse models of diet-induced obesity (reviewed in Surmi and Hasty 7 ), the most prominent neutrophil and macrophage chemoattractants are interleukin-8 (IL-8) and monocyte chemotactic protein-1 (MCP-1), respectively. Macrophages contribute to the production of pro-inflammatory cytokines (such as TNF-a and IL-6) in the adipose tissue, thereby contributing to the establishment of chronic low-grade inflammatory state, characteristic of obesity. IL-8 expression has not been studied longitudinally, but increase in MCP-1 expression appears to occur early, coinciding with neutrophil and macrophage influx into adipose tissue. In contrast, increases in macrophage inflammatory protein-1b (MIP-1b) appear to occur later, after obesity is well established.
Among the studies of chemokines in children, few have focused on obesity or insulin resistance. Of these, IL-8 levels were unrelated to weight in two studies, 8, 9 and related to weight only in adolescent girls in a third. 10 MCP-1 was correlated with the degree of overweight, and a decrease in MCP-1 levels was associated with weight loss. 4 Although overexpression of MCP-1 was shown to cause insulin resistance in a mouse model, 11 no studies in adolescents, to date, have reported an association between the chemokines IL-8, MCP-1 or MIP-1b and insulin resistance. [8] [9] [10] Studies of visfatin with insulin resistance in children have reported conflicting results. [12] [13] [14] The present cross-sectional study in 18-21-year-olds was conducted in a cohort of individuals who were participating in a longitudinal study, beginning at mean age 13, of the influence of obesity and insulin resistance on the development of cardiovascular (CV) risk. This report is focused on four chemokines to determine whether there is a significant relation between these chemoattractants and factors associated with CV risk and inflammation in late adolescence/early young adulthood.
SUBJECTS AND METHODS

Study participants
The study was approved by the Institutional Review Board Human Subjects Committee of the University of Minnesota. Informed consent was obtained from all participants. 1 The participants in this study were among 357 children who were randomly recruited after screening of blood pressure (BP), height and weight in 12 043 5-8 grade Minneapolis Public School students, as previously described 14 . Participants were randomly selected from among the screenees, with half from those in the top quartile and half from those in the bottom three quarters of systolic BP. Children with any chronic illness were excluded. The participants were followed with repeated clinic visits and laboratory studies at mean ages 13, 15 and 19. The cohort for the present study consists of 252 participants who were seen at the mean age 19 (18-21 years) evaluation. There were no significant differences in the baseline data between these individuals and the other 105 original participants.
Participants were seen in a clinic dedicated to this study for BP and anthropometric measurements. Height was measured by a wall-mounted stadiometer. Weight was measured by a balance scale. BP was measured twice on the right arm using a random-zero sphygmomanometer with participants seated; the averages of the two measurements (systolic and fifth phase Korotkoff diastolic) were used in the analyses.
The laboratory and insulin clamp studies were conducted at the University of Minnesota Clinical and Translational Science Institute as previously described. 15 Blood samples for fasting serum insulin levels, triglycerides, HDL-C, adipocytokines and the chemokines were obtained at baseline (before starting the insulin infusion). Plasma glucose was measured at baseline and every 5 min during the clamp. The insulin infusion was started at time 0 and continued at 1 mU kg À 1 min À 1 for 3 h. An infusion of 20% glucose was started at time 0 and adjusted, based on plasma glucose levels, to maintain plasma glucose at 5.6 mmol l À 1 (100 mg dl À 1 ). Insulin sensitivity, M, was determined from the amount of glucose administered over the final 40 min of the euglycemic clamp and was expressed as M lbm (that is, glucose utilization per kg lean body mass per minute). Lean body mass, or fat-free mass, was calculated by dual-energy X-ray absorptiometry.
Blood samples were analyzed for glucose immediately at the bedside with a Beckman Glucose Analyzer II (Beckman Instruments Inc., Fullerton, CA, USA). Insulin levels (radioimmunoassay) and serum lipids were determined in the laboratory of the Fairview-University Medical Center, as previously reported. 15 Blood samples obtained for chemokine and adipocytokine analyses were immediately processed by centrifugation and serum samples were stored frozen at À 80 1C and thawed only once for multiplex analysis and enzyme-linked immunosorbent assay. IL-6, TNF-a and adiponectin were measured by enzyme-linked immunosorbent assay in the cytokine reference laboratory of the University of Minnesota. The intra-assay and inter-assay coefficients of variation for IL-6 are 1.6-2.4 and 3.3-6.4, respectively, for high-sensitivity TNF-a, 5.3-8.8 and 10.8-16.7, respectively, and for adiponectin, 2.5-4.7 and 5.8-6.9, respectively.
Chemokine assays were performed in the laboratory of SO. Visfatin levels were measured by enzyme-linked immunosorbent assay (Phoenix Pharmaceuticals Inc., Burlingame, CA, USA). The intra-assay and inter-assay coefficients of variation were 2.6-5.1 and 10.5-12.8, respectively. IL-8, MCP-1 and MIP-1b were measured simultaneously by multiplex immunoassay (Luminex, Austin, TX, USA), according to the manufacturer's instructions (Biorad, Hercules, CA, USA). Briefly, 50 ml of the standard or 1:3 dilution of test serum sample was combined with the beads in 1:1 ratio. After 30 min incubation at room temperature, the plates were washed and 25 ml of biotinylated detection antibody was added to each well. After 30 min incubation, the plates were washed and 50 ml of streptavidinphycoerythrin was added to each well followed by a 10-min incubation. The beads were then resuspended in 125 ml assay buffer and analyzed on a Luminex 200 instrument (Luminex) using Bioplex Manager Software 4.1 (Biorad). A minimum of 50 beads per region were analyzed; a fiveparameter logistic curve was applied to each standard curve and cytokine concentrations were interpolated from these curves. Based on the blinded quality control samples, the highest intra-assay and inter-assay coefficients of variation were: 9.5 and 15.8, respectively, for IL-8, 11.9 and 20.4, respectively, for MIP-1b and 12.3 and 22.6, respectively, for MCP-1.
Statistical analyses
Continuous variables were assessed for normality and in transformation as an alternate representation for IL-6, the only variable that showed strong skewness. Differences between boys and girls were compared by unpaired t-test. Pearson's correlation coefficients and multiple linear regression were used to analyze the associations between the four chemokines and the CV-risk factors (anthropometric measures, lipids and BP), and factors associated with insulin resistance and the cytokines. Adjustment was for age, race and sex; an alternate model added body mass index (BMI) as a covariate.
RESULTS
The cohort consisted of 143 males and 109 females ( Table 1 ). The BMI distribution was as follows: normal (BMIo25) 149 (59%), Chemokines, BMI and insulin resistance S Ognjanovic et al overweight (BMI 25 to o30) 59 (23%) and obese (BMIX30) 44 (18%). Impaired fasting glucose was found in 22 (9%), and 1 participant had a fasting glucose 4125 mg dl À 1 . None of the participants were hypertensive. Males were significantly taller and heavier, but BMI was not significantly different between genders. Males had higher triglycerides, glucose levels and systolic BP. Females had significantly higher insulin sensitivity (M lbm ), HDL cholesterol and adiponectin. The chemokines (visfatin, IL-8, MCP-1 and MIP-1b) were not significantly different between the genders and there were no significant differences in any of the variables by ethnicity (data not shown).
There were a number of significant relations among the chemokines (Table 2) . MCP-1 was significantly related to all three of the other chemokines. MIP-1b and visfatin were significantly related to MCP-1 and with each other. IL-8 was significantly correlated only with MCP-1.
Several variables had significant associations both in models adjusted for age, race and sex, and in those also adjusted for BMI (Table 3 ). These associations included MIP-1b with waist and IL-6, IL-8 with SBP and visfatin with IL-6. None of the chemokines was significantly associated with glucose, lipids, fasting insulin or insulin resistance. Because some variables in the study differed significantly between males and females (Table 1) , the associations between the chemokines and the other variables were analyzed by gender (data not shown). These analyses also showed very few significant relations. MIP-1b was significantly associated with waist only in females (r ¼ 0.24, Po0.05), and MCP-1 and IL-8 were negatively associated with systolic BP in males (r ¼ À 0.34, Po0.002 and r ¼ À 0.21, P ¼ 0.05, respectively).
DISCUSSION
The results from this study show that in late adolescence/early young adulthood (age 18-21 years), although there is a significant relation among the serum concentrations of the chemokines (IL-8, MCP-1, MIP-1b and visfatin), there were few significant associations with CV-related factors.
Prior studies have examined serum concentrations of some chemokines in healthy normal weight and overweight children. The IL-8 levels in lean and overweight adolescent children were not significantly different at mean ages 8, 10 11, 9 and 15 years, 8, 10 although a subgroup analysis showed a positive association in 8-year-old girls. 10 In the present study of slightly older individuals, no gender differences were found. We are aware of only a single study that examined MCP-1 levels in children (mean age 11) and showed a positive association with BMI. 9 In this study, there were no significant association for MCP-1 and only MIP-1b expression was significantly higher in overweight compared with normalweight participants. Studies of visfatin and insulin resistance in children have reported both significant 12 and nonsignificant associations. 13, 14 No significant associations between visfatin and BMI or insulin resistance were found, either in normal or overweight individuals in this study.
Animal studies suggest that macrophage-derived pro-inflammatory cytokines and chemokines underlie the mechanisms linking obesity, inflammation and defects in insulin sensitivity. 16 Mice lacking the MCP-1 receptor have reduced macrophage infiltration in adipose tissue and exhibit partial protection from high-fat diet-induced insulin resistance. 17 Similarly, mice lacking MIP-1a, 18 osteopontin, 19 and MCP-1 20 were shown to be protected from obesity-induced macrophage infiltration of adipose tissue and insulin resistance, although the finding for MCP-1 was not confirmed. 21 Increased expression of MIP-1a and MCP-1 genes in the fat depot of obese mice was shown to precede the increase in insulin production, whereas the insulinsensitizing drug rosiglitazone reduced their expression. 18 In vitro studies using adipocyte cells and human muscle cells showed MCP-1-related impairment of insulin signaling and reduced insulin-dependent glucose uptake.
11,22 MCP-1 levels in adults were correlated with measures of adiposity 23, 24 and were reduced upon weight loss. 23, 25 In addition, adult diabetic patients were shown to have higher MCP-1 levels compared with controls. 26, 27 Based on these observation, MCP-1 was suggested to be an inflammatory factor linking obesity and insulin resistance. 16 In contrast, studies in children and adolescents, to date, failed to show a direct association between the chemokines and insulin resistance, although stress-induced inflammation in children who suffered severe burns has been reported to be associated with high levels of MCP-1 and MIP-1b, which were proposed to be related to the development of insulin resistance. Based on prior studies in children and the finding of very few significant relations between the chemokines and variables in this study of 18-21-year-olds, it appears these associations may not develop until some point in later adult life. There are some potential limitations to this study. The study is cross-sectional with 252 of the original 357 participants recruited from the Minneapolis school system and IL-8 was assessed in only 160 subjects. However, the participants were originally randomly selected, there were no significant differences in the anthropometric or laboratory variables between the subjects in this chemokine study and the nonparticipants, and the cohort is well characterized with CV-risk variables (anthropometric measures, lipids and BP), insulin resistance and cytokines that enabled evaluation of chemokine relations. The percentage of Blacks is relatively low, as a result of the population in the Minneapolis public schools at the time of the original recruitment. However, the current percentage in this study (17.5%) is similar to the percentage (20.5%) at the time the cohort was recruited. Another limitation is that only proxy estimates of adiposity (BMI and waist circumference) were used, and an association may have been found with more accurate measurements of body fat. Multiple comparisons used in the analyses of chemokines and a number of outcome variables may have increased the risk of chance findings, and we have, therefore, made cautious interpretation of those few nominally significant relations that we did see between the chemokines and other variables.
28
In summary, the present study reports associations between chemokines and CV-risk factors, and insulin resistance and cytokines in 18-21-year-olds. Considering these results in relation to prior studies in children, adolescents and adults suggests that the relation between chemokines and the other risk factor and metabolic variables is not apparent until after early adulthood.
